{"id":"https://openalex.org/W2107950329","doi":"https://doi.org/10.1176/appi.ajp.2013.13070985","title":"Lurasidone as Adjunctive Therapy With Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study","display_name":"Lurasidone as Adjunctive Therapy With Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study","publication_year":2013,"publication_date":"2013-10-30","ids":{"openalex":"https://openalex.org/W2107950329","doi":"https://doi.org/10.1176/appi.ajp.2013.13070985","mag":"2107950329","pmid":"https://pubmed.ncbi.nlm.nih.gov/24170221"},"language":"en","primary_location":{"id":"doi:10.1176/appi.ajp.2013.13070985","doi":"https://doi.org/10.1176/appi.ajp.2013.13070985","is_oa":false,"landing_page_url":"https://doi.org/10.1176/appi.ajp.2013.13070985","pdf_url":null,"source":{"id":"https://openalex.org/S116025658","display_name":"American Journal of Psychiatry","issn_l":"0002-953X","issn":["0002-953X","1535-7228"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066553937","display_name":"Antony D Loebel","orcid":"https://orcid.org/0000-0002-7591-8647","observed_orcids":["https://orcid.org/0000-0002-7591-8647"]},"institutions":[{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]},{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Antony Loebel","raw_affiliation_strings":["From Sunovion Pharmaceuticals, Inc., Fort Lee, N.J., and Marlborough, Mass.; and University Hospitals Case Medical Center, Case Western Reserve University, Cleveland","Sunovion Pharmaceuticals Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Sunovion Pharmaceuticals, Inc., Fort Lee, N.J., and Marlborough, Mass.; and University Hospitals Case Medical Center, Case Western Reserve University, Cleveland","institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I58956616"]},{"raw_affiliation_string":"Sunovion Pharmaceuticals Inc","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028328307","display_name":"Josephine B. Cucchiaro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]},{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Josephine Cucchiaro","raw_affiliation_strings":["From Sunovion Pharmaceuticals, Inc., Fort Lee, N.J., and Marlborough, Mass.; and University Hospitals Case Medical Center, Case Western Reserve University, Cleveland","Sunovion Pharmaceuticals Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Sunovion Pharmaceuticals, Inc., Fort Lee, N.J., and Marlborough, Mass.; and University Hospitals Case Medical Center, Case Western Reserve University, Cleveland","institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I58956616"]},{"raw_affiliation_string":"Sunovion Pharmaceuticals Inc","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007892806","display_name":"Robert Silva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]},{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Silva","raw_affiliation_strings":["From Sunovion Pharmaceuticals, Inc., Fort Lee, N.J., and Marlborough, Mass.; and University Hospitals Case Medical Center, Case Western Reserve University, Cleveland","Sunovion Pharmaceuticals Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Sunovion Pharmaceuticals, Inc., Fort Lee, N.J., and Marlborough, Mass.; and University Hospitals Case Medical Center, Case Western Reserve University, Cleveland","institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I58956616"]},{"raw_affiliation_string":"Sunovion Pharmaceuticals Inc","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hans Kroger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]},{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hans Kroger","raw_affiliation_strings":["From Sunovion Pharmaceuticals, Inc., Fort Lee, N.J., and Marlborough, Mass.; and University Hospitals Case Medical Center, Case Western Reserve University, Cleveland","Sunovion Pharmaceuticals Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Sunovion Pharmaceuticals, Inc., Fort Lee, N.J., and Marlborough, Mass.; and University Hospitals Case Medical Center, Case Western Reserve University, Cleveland","institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I58956616"]},{"raw_affiliation_string":"Sunovion Pharmaceuticals Inc","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001940742","display_name":"Kaushik Sarma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]},{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kaushik Sarma","raw_affiliation_strings":["From Sunovion Pharmaceuticals, Inc., Fort Lee, N.J., and Marlborough, Mass.; and University Hospitals Case Medical Center, Case Western Reserve University, Cleveland","Sunovion Pharmaceuticals Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Sunovion Pharmaceuticals, Inc., Fort Lee, N.J., and Marlborough, Mass.; and University Hospitals Case Medical Center, Case Western Reserve University, Cleveland","institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I58956616"]},{"raw_affiliation_string":"Sunovion Pharmaceuticals Inc","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006428715","display_name":"Jane Xu","orcid":"https://orcid.org/0000-0003-3619-2676","observed_orcids":["https://orcid.org/0000-0003-3619-2676"]},"institutions":[{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]},{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jane Xu","raw_affiliation_strings":["From Sunovion Pharmaceuticals, Inc., Fort Lee, N.J., and Marlborough, Mass.; and University Hospitals Case Medical Center, Case Western Reserve University, Cleveland","Sunovion Pharmaceuticals Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Sunovion Pharmaceuticals, Inc., Fort Lee, N.J., and Marlborough, Mass.; and University Hospitals Case Medical Center, Case Western Reserve University, Cleveland","institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I58956616"]},{"raw_affiliation_string":"Sunovion Pharmaceuticals Inc","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039228625","display_name":"Joseph R. Calabrese","orcid":"https://orcid.org/0000-0003-4647-8571","observed_orcids":["https://orcid.org/0000-0003-4647-8571","https://orcid.org/0000-0003-1010-2951"]},"institutions":[{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph R. Calabrese","raw_affiliation_strings":["From Sunovion Pharmaceuticals, Inc., Fort Lee, N.J., and Marlborough, Mass.; and University Hospitals Case Medical Center, Case Western Reserve University, Cleveland","Psychiatry"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Sunovion Pharmaceuticals, Inc., Fort Lee, N.J., and Marlborough, Mass.; and University Hospitals Case Medical Center, Case Western Reserve University, Cleveland","institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I58956616"]},{"raw_affiliation_string":"Psychiatry","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":19.8422,"has_fulltext":false,"cited_by_count":294,"citation_normalized_percentile":{"value":0.99742558,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"171","issue":"2","first_page":"169","last_page":"177"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lurasidone","display_name":"lurasidone","score":1.0},{"id":"https://openalex.org/keywords/bipolar-i-depression","display_name":"bipolar I depression","score":0.9319999814033508},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.9430000185966492},{"id":"https://openalex.org/keywords/lithium","display_name":"lithium","score":0.9929999709129333},{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":1.0},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.878000020980835},{"id":"https://openalex.org/keywords/mood-stabilizers","display_name":"mood stabilizers","score":0.8199999928474426},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.8019999861717224},{"id":"https://openalex.org/keywords/depression-severity","display_name":"depression severity","score":0.5740000009536743},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5979999899864197},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.6909999847412109},{"id":"https://openalex.org/keywords/functional-disability","display_name":"functional disability","score":0.9269999861717224}],"concepts":[{"id":"https://openalex.org/C2776701107","wikidata":"https://www.wikidata.org/wiki/Q416992","display_name":"Lurasidone","level":4,"score":0.9341124296188354},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6693016886711121},{"id":"https://openalex.org/C3018162438","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Adjunctive treatment","level":2,"score":0.6024444699287415},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.5170684456825256},{"id":"https://openalex.org/C2777393122","wikidata":"https://www.wikidata.org/wiki/Q416417","display_name":"Akathisia","level":4,"score":0.4565649926662445},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.45189714431762695},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4516991972923279},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44893723726272583},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.42098289728164673},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.4209710359573364},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3873693645000458},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.3627714514732361},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3355887532234192},{"id":"https://openalex.org/C2778541603","wikidata":"https://www.wikidata.org/wiki/Q152763","display_name":"Lithium (medication)","level":2,"score":0.3175341486930847},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.11860156059265137},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069056","descriptor_name":"Lurasidone Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018020","descriptor_name":"Lithium Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018692","descriptor_name":"Antimanic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054833","descriptor_name":"Isoindoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D054833","descriptor_name":"Isoindoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1176/appi.ajp.2013.13070985","doi":"https://doi.org/10.1176/appi.ajp.2013.13070985","is_oa":false,"landing_page_url":"https://doi.org/10.1176/appi.ajp.2013.13070985","pdf_url":null,"source":{"id":"https://openalex.org/S116025658","display_name":"American Journal of Psychiatry","issn_l":"0002-953X","issn":["0002-953X","1535-7228"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Psychiatry","raw_type":"journal-article"},{"id":"pmid:24170221","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24170221","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of psychiatry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W143336295","https://openalex.org/W590310416","https://openalex.org/W1970133878","https://openalex.org/W1970476994","https://openalex.org/W1977370435","https://openalex.org/W1980334180","https://openalex.org/W1984708171","https://openalex.org/W1987450550","https://openalex.org/W2006723017","https://openalex.org/W2007929837","https://openalex.org/W2009832071","https://openalex.org/W2011797837","https://openalex.org/W2011905433","https://openalex.org/W2015477517","https://openalex.org/W2017848792","https://openalex.org/W2031748346","https://openalex.org/W2032446177","https://openalex.org/W2044827759","https://openalex.org/W2059340233","https://openalex.org/W2059519261","https://openalex.org/W2059553143","https://openalex.org/W2066671649","https://openalex.org/W2067369841","https://openalex.org/W2107231683","https://openalex.org/W2111355579","https://openalex.org/W2114710465","https://openalex.org/W2120839478","https://openalex.org/W2122405388","https://openalex.org/W2123315863","https://openalex.org/W2131823335","https://openalex.org/W2137044087","https://openalex.org/W2137865998","https://openalex.org/W2160070901","https://openalex.org/W2163368530","https://openalex.org/W2166033924","https://openalex.org/W2167659819","https://openalex.org/W2170348479","https://openalex.org/W2324545061","https://openalex.org/W3171418018"],"related_works":["https://openalex.org/W2324187437","https://openalex.org/W4394953607","https://openalex.org/W1987935555","https://openalex.org/W2163368530","https://openalex.org/W2119096913","https://openalex.org/W4298064942","https://openalex.org/W2983484633","https://openalex.org/W3188802644","https://openalex.org/W4229816661","https://openalex.org/W3080584333"],"abstract_inverted_index":{"OBJECTIVE":[0],"Few":[1],"studies":[2],"have":[3,20],"been":[4],"reported":[5,204],"that":[6],"support":[7],"the":[8,33,49,96,107,133,194],"efficacy":[9,34],"of":[10,35,51,64,78,176,178,221],"adjunctive":[11,42,66,240],"therapy":[12,43],"for":[13,48,112,205],"patients":[14,232],"with":[15,27,44,68,132,156,228,233,238],"bipolar":[16,52,115,234],"I":[17,53,235],"depression":[18,103,152],"who":[19],"had":[21],"an":[22],"insufficient":[23],"response":[24],"to":[25,60,75,92,186,241],"monotherapy":[26],"mood-stabilizing":[28],"agents.":[29],"The":[30],"authors":[31],"investigated":[32],"lurasidone,":[36],"a":[37],"novel":[38],"antipsychotic":[39],"agent,":[40],"as":[41,163,165],"lithium":[45,80,242],"or":[46,71,81,243],"valproate":[47,244],"treatment":[50,67,121,143,227,237],"depression.":[54],"METHOD":[55],"Patients":[56],"were":[57,88,189,207,224],"randomly":[58],"assigned":[59],"receive":[61],"6":[62,94,130],"weeks":[63],"double-blind":[65],"lurasidone":[69,142,195,206,239],"(N=183)":[70],"placebo":[72,134,157,197],"(N=165),":[73],"added":[74],"therapeutic":[76],"levels":[77],"either":[79],"valproate.":[82],"Primary":[83],"and":[84,102,172,180,191,196,212,219,249],"key":[85],"secondary":[86],"endpoints":[87],"change":[89],"from":[90],"baseline":[91],"week":[93,129],"on":[95,106],"Montgomery-\u00c5sberg":[97],"Depression":[98],"Rating":[99],"Scale":[100],"(MADRS)":[101],"severity":[104,153],"score":[105,127],"Clinical":[108],"Global":[109],"Impressions":[110],"scale":[111],"use":[113],"in":[114,145,150,169,173,193,216],"illness":[116],"(CGI-BP),":[117],"respectively.":[118,199],"RESULTS":[119],"Lurasidone":[120],"significantly":[122,146,166,245],"reduced":[123],"mean":[124],"MADRS":[125],"total":[126],"at":[128],"compared":[131,155],"group":[135],"(-17.1":[136],"versus":[137,159],"-13.5;":[138],"effect":[139,161],"size=0.34).":[140],"Similarly,":[141],"resulted":[144],"greater":[147,167],"endpoint":[148],"reduction":[149],"CGI-BP":[151],"scores":[154],"(-1.96":[158],"-1.51;":[160],"size=0.36)":[162],"well":[164,252],"improvement":[168],"anxiety":[170],"symptoms":[171,248],"patient-reported":[174],"measures":[175,220],"quality":[177],"life":[179],"functional":[181],"impairment.":[182],"Discontinuation":[183],"rates":[184],"due":[185],"adverse":[187],"events":[188,201],"6.0%":[190],"7.9%":[192],"groups,":[198],"Adverse":[200],"most":[202],"frequently":[203],"nausea,":[208],"somnolence,":[209],"tremor,":[210],"akathisia,":[211],"insomnia.":[213],"Minimal":[214],"changes":[215],"weight,":[217],"lipids,":[218],"glycemic":[222],"control":[223],"observed":[225],"during":[226],"lurasidone.":[229],"CONCLUSIONS":[230],"In":[231],"depression,":[236],"improved":[246],"depressive":[247],"was":[250],"generally":[251],"tolerated.":[253]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":14},{"year":2023,"cited_by_count":17},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":24},{"year":2020,"cited_by_count":23},{"year":2019,"cited_by_count":50},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":21},{"year":2016,"cited_by_count":17},{"year":2015,"cited_by_count":53},{"year":2014,"cited_by_count":26},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}